Literature DB >> 21511382

Arguments against corticosteroids in community acquired pneumonia.

Felipe Rodríguez de Castro, Jordi Solé-Violán.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21511382      PMCID： PMC7129869          DOI： 10.1016/j.arbres.2011.02.011

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN： 0300-2896            Impact factor:   4.872


× No keyword cloud information.
  26 in total

1.  [Inflammatory response in pneumonia: are glucocorticosteroids useful?].

Authors:  C Agustí; A Torres
Journal:  Arch Bronconeumol       Date:  2003-04       Impact factor: 4.872

2.  [Community acquired pneumonia. New guidelines of the Spanish Society of Chest Diseases and Thoracic Surgery (SEPAR)].

Authors:  Rosario Menéndez; Antoni Torres; Javier Aspa; Alberto Capelastegui; Cristina Prat; Felipe Rodríguez de Castro
Journal:  Arch Bronconeumol       Date:  2010-09-15       Impact factor: 4.872

3.  Adrenal function is related to prognosis in moderate community-acquired pneumonia.

Authors:  M Kolditz; M Halank; B Schulte-Hubbert; G Höffken
Journal:  Eur Respir J       Date:  2010-01-28       Impact factor: 16.671

4.  Acute respiratory failure in patients with severe community-acquired pneumonia. A prospective randomized evaluation of noninvasive ventilation.

Authors:  M Confalonieri; A Potena; G Carbone; R D Porta; E A Tolley; G Umberto Meduri
Journal:  Am J Respir Crit Care Med       Date:  1999-11       Impact factor: 21.405

5.  Hydrocortisone and tumor necrosis factor in severe community-acquired pneumonia. A randomized controlled study.

Authors:  P Marik; P Kraus; J Sribante; I Havlik; J Lipman; D W Johnson
Journal:  Chest       Date:  1993-08       Impact factor: 9.410

6.  Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine.

Authors:  Paul E Marik; Stephen M Pastores; Djillali Annane; G Umberto Meduri; Charles L Sprung; Wiebke Arlt; Didier Keh; Josef Briegel; Albertus Beishuizen; Ioanna Dimopoulou; Stylianos Tsagarakis; Mervyn Singer; George P Chrousos; Gary Zaloga; Faran Bokhari; Michael Vogeser
Journal:  Crit Care Med       Date:  2008-06       Impact factor: 7.598

7.  Effects of systemic steroids in patients with severe community-acquired pneumonia.

Authors:  C Garcia-Vidal; E Calbo; V Pascual; C Ferrer; S Quintana; J Garau
Journal:  Eur Respir J       Date:  2007-08-09       Impact factor: 16.671

8.  Adrenal response in severe community-acquired pneumonia: impact on outcomes and disease severity.

Authors:  Jorge I F Salluh; Fernando A Bozza; Márcio Soares; Juan Carlos R Verdeal; Hugo C Castro-Faria-Neto; José Roberto Lapa E Silva; Patrícia T Bozza
Journal:  Chest       Date:  2008-08-27       Impact factor: 9.410

9.  Hydrocortisone therapy for patients with septic shock.

Authors:  Charles L Sprung; Djillali Annane; Didier Keh; Rui Moreno; Mervyn Singer; Klaus Freivogel; Yoram G Weiss; Julie Benbenishty; Armin Kalenka; Helmuth Forst; Pierre-Francois Laterre; Konrad Reinhart; Brian H Cuthbertson; Didier Payen; Josef Briegel
Journal:  N Engl J Med       Date:  2008-01-10       Impact factor: 91.245

10.  Efficacy of corticosteroids in the treatment of community-acquired pneumonia requiring hospitalization.

Authors:  Katsunaka Mikami; Masaru Suzuki; Hiroshi Kitagawa; Masaki Kawakami; Nobuaki Hirota; Hiromichi Yamaguchi; Osamu Narumoto; Yoshiko Kichikawa; Makoto Kawai; Hiroyuki Tashimo; Hidenori Arai; Tadashi Horiuchi; Yoshio Sakamoto
Journal:  Lung       Date:  2007-08-21       Impact factor: 3.777
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.